Skip to main content
Clinical Trials/NCT03928899
NCT03928899
Unknown
Not Applicable

The Best Timing of Delivery in Women With GDM That is Controlled With Only Diet and Exercise

Peking University First Hospital1 site in 1 country230 target enrollmentJuly 15, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
Peking University First Hospital
Enrollment
230
Locations
1
Primary Endpoint
caesarean section rate
Last Updated
4 years ago

Overview

Brief Summary

The investigatiors aimed to conduct a well-designed RCT to firstly focus on GDM women controlled with only diet and exercise, and provide an optimize process on their timing and mode of delivery

Detailed Description

GDM is a common complication of pregnancy and even mildly hyperglycemia could significantly affect fetal growth. Optimal delivery timing in women with GDM remains controversial. This decision process involves balancing the potential for complications that are caused by increased interventions with the benefit of avoidance of future adverse outcomes. Thus, the aim of the present trial is to explore the best management on the timing of delivery of pregnant women with GDM that controlled with only diet and exercise, which can both decrease the risk of macrosomia and the risk of cesarean delivery.

Registry
clinicaltrials.gov
Start Date
July 15, 2019
End Date
December 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wang Chen

Doctor

Peking University First Hospital

Eligibility Criteria

Inclusion Criteria

  • singleton pregnant women
  • in vertex presentation
  • GDM that is controlled with only diet and exercise
  • at 37 weeks 0 days to 37 weeks 6 days of gestation
  • more than 18 years old
  • have no other contraindications to vaginal delivery.

Exclusion Criteria

  • prior caesarean section or myomectomy
  • any known contraindications to vaginal delivery
  • uncertain gestational age
  • non reassuring foetal wellbeing necessitating delivery
  • maternal pregnancy-related disease necessitating delivery (any hypertensive disorder, cardiac disease, renal insufficiency、immune diseases, et al.)
  • placenta previa, accreta, vasa previa
  • known foetal anomaly
  • negative reproductive history
  • ruptured membranes or known oligohydramnios (defined as AFI \< 5 or MVP \< 2 ) before 37weeks 6 days of gestation
  • fetal growth restriction, defined as EFW \< 10th percentile

Outcomes

Primary Outcomes

caesarean section rate

Time Frame: 41weeks

Secondary Outcomes

  • oxygen required(41weeks)
  • rate of labor pain(41weeks)
  • intrapartum complications(41weeks)
  • neonatal plasma glucose level collected 1-2h after delivery(41weeks)
  • neonatal hypoglycemia(41weeks)
  • death before discharge from hospital(41weeks)
  • Apgar at 1 min, Apgar at 5 min, Apgar at 10 minutes(41weeks)
  • cord blood artery pH(41weeks)
  • hypotonia(41weeks)
  • mode of delivery(41weeks)
  • operative vaginal delivery indication(41weeks)
  • method of induction of labour(41weeks)
  • indication for induction(41weeks)
  • neonatal sex(41weeks)
  • stillbirth(41weeks)
  • neonatal respiratory distress(41weeks)
  • the mothers' expectations and experience of childbirth(41weeks)
  • onset of labour(41weeks)
  • shoulder dystocia(41weeks)
  • birth trauma(41weeks)
  • caesarean section indication(41weeks)
  • gestational age(41weeks)
  • birth weight(41weeks)
  • NICU admission(41weeks)
  • seizures(41weeks)
  • intubation and ventilation for > 24 h(41weeks)
  • the utilization of medical resources(41weeks)

Study Sites (1)

Loading locations...

Similar Trials